- PMLiVE

Connectome competitiveness

It’s not what you do, it’s how what you do connects

- PMLiVE

In uncertain times, plan for the actions you may never take

To be successful in changeable times, we must elevate the way we create our brand plans

- PMLiVE

Pro bono publico

Seven key principles for success for pro bono working

- PMLiVE

Merck reports positive results for Keytruda combination in phase 3 gastric cancer trial

Over one million new cases of gastric cancer were diagnosed globally in 2020

- PMLiVE

Facts are stubborn things

California tried to tell doctors what would be classified as misinformation – it didn’t go well

- PMLiVE

Declining disruption

Innovation may be becoming less innovative

- PMLiVE

Making a human connection – the lost art of the brand narrative

Understanding the five mistakes to avoid in order to ensure brand success

- PMLiVE

Making new year resolutions that can also benefit others

Consider resolutions that could make 2023 a better year for many

A bundle of nerves

Medical experts have determined that we need to screen everyone for anxiety − and I mean everyone

- PMLiVE

Microfoundations matter

If you want to change in 2023, sweat the small stuff

- PMLiVE

MIT researchers develop AI model to detect future lung cancer risk

Lung cancer is the leading cause of cancer in the US, accounting for 1.7 million deaths globally in 2020

- PMLiVE

World Antimicrobial Awareness Week 2022

Reports from the World Health Organization show that AMR is one of the top ten threats to global health, causing 1.3 million deaths in 2019

- PMLiVE

Design considerations and best practices in clinical research

The increased focus on precision medicine in oncology and rare diseases has led to a marked increase of single-arm trials

- PMLiVE

Unlocking the potential of data sharing

The impact of privacy issues on clinical trials – how these issues limit studies and how they can be optimised